ISPOR Europe 2022 – inside the second plenary: understanding what is important to patients

Having committed to the use of RWE, regulatory agencies including the EMA and FDA are increasingly interested in the use of patient-centered end points. But how can real-world patient-centered research be conducted across countries? Here, I share my takeaways from the second plenary session at ISPOR Europe 2022 (6–9 November; Vienna, Austria). The second plenary session at ISPOR Europe 2022 was entitled “Real-World Patient-Centered Research: Is It Possible Across Countries?”. Moderated by Tara Symonds (Clinical Outcomes Solutions Ltd, UK), the session included panelists Juan García Burgos (European Medicines Agency, The Netherlands), Nancy Devlin (University of Melbourne, Australia) and Eleanor M...